Viewing Study NCT01192295


Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2026-02-03 @ 1:54 AM
Study NCT ID: NCT01192295
Status: COMPLETED
Last Update Posted: 2020-03-23
First Post: 2010-08-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Sponsor: Purdue Pharma LP
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Malignant pain View
None Nonmalignant pain View
None Pediatric View
None Opioid View
None Moderate to severe malignant or nonmalignant pain View